Adopt Universal Screening for Pregnant Women - Revision history

Mredden at 20:16, 6 April 2021

2021-04-06T20:16:58Z

Mredden at 16:28, 8 February 2021

2021-02-08T16:28:14Z

Mredden at 16:27, 8 February 2021

2021-02-08T16:27:56Z

Pkalch at 17:21, 2 April 2020

2020-04-02T17:21:53Z

Dmt7109 at 20:18, 15 March 2020

2020-03-15T20:18:44Z

Dmt7109 at 20:18, 15 March 2020

2020-03-15T20:18:21Z

Dmt7109 at 20:17, 15 March 2020

2020-03-15T20:17:58Z

Dmt7109: Undo revision 19769 by Dmt7109 (talk)

2020-03-15T20:17:02Z

Undo revision 19769 by Dmt7109 (talk)

Dmt7109: Replaced content with "XML Parsing Error: syntax error"

2020-03-15T20:16:35Z

Replaced content with "<parsererror xmlns="http://www.mozilla.org/newlayout/xml/parsererror.xml">XML Parsing Error: syntax error</parsererror>"

Josiebeets at 23:18, 24 November 2019

2019-11-24T23:18:21Z

← Older revision		Revision as of 20:16, 6 April 2021
Line 63:		Line 63:

	[[TR_-_Adopt_Universal_Screening_for_Pregnant_Women\|TR - Adopt Universal Screening for Pregnant Women]]		[[TR_-_Adopt_Universal_Screening_for_Pregnant_Women\|TR - Adopt Universal Screening for Pregnant Women]]
−
−	~~=   =~~
−
−	~~ ~~

	----		----

@@ Line 70: / Line 70: @@
 ----
-Sources
+= Sources =
 #[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]

@@ Line 1: / Line 1: @@
-<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
+<div class="wiki" id="content_view" style="display: block">
 Return to&nbsp; [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]
 __TOC__
-<br/> Another potential strategy is to universally screen all pregnant women for substance abuse. In Kaiser Permanente's [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start ]program, pregnant women were screened for substance abuse risk at the first prenatal visit by a self-administered questionnaire and by urine toxicology testing (with signed consent). Universal screening facilitates early identification and treatment of substance use.<sup class="reference">[1]</sup><br/> <br/> '''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start: An Integrated Model of Substance Abuse Intervention for Pregnant Women] - Kaiser Permanente'''<br/> ''Overview of program'':
+= <br/> Overview =
 *Universally screen all pregnant women
@@ Line 17: / Line 25: @@
 *Reduces all barriers to care, including in prenatal care
-<br/> '''[http://www.ajog.org/article/S0002-9378(16)30383-0/fulltext#tbl4 The role of screening, brief intervention, and referral to treatment in the perinatal period -- Tricia E. Wright, MD, MS]'''<br/> ''Method'':
+'''[http://www.ajog.org/article/S0002-9378(16)30383-0/fulltext#tbl4 The role of screening, brief intervention, and referral to treatment in the perinatal period -- Tricia E. Wright, MD, MS]'''<br/> ''Method'':
 ''Screening Instruments:''
@@ Line 34: / Line 42: @@
 *Urine toxicology should not be used in place of screening
-&nbsp;
+= Impactful Federal, State, and Local Policies =
 = Promising Practices for Standardized Screening =
@@ Line 43: / Line 51: @@
 &nbsp; To understand and address perinatal substance use, accurate data needed to be collected through '''standardized screening and testing:'''
 *When any pregnant arrives at the hospital for delivery, hospital personnel conduct a standardized and validated verbal screening regarding substance use.
@@ Line 52: / Line 58: @@
 *Babies also have modified Finnegan scoring initiated to observe for signs and symptoms of NAS.
-<br/> ISDH noted that universal screening in a [[Shift_from_Punishment_to_Treatment_Approach_for_Opioid_Users|non-punitive]] environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.<sup class="reference">[2]</sup><br/> <br/> ''See [[Improve_Identifying_and_Data_Collection_on_NAS|Improve Identifying and Data Collecting on NAS]] for more information on defining, testing, and reporting data about NAS.''<br/> &nbsp;
+ISDH noted that universal screening in a [[Shift_from_Punishment_to_Treatment_Approach_for_Opioid_Users|non-punitive]] environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.<sup class="reference">[2]</sup><br/> <br/> ''See [[Improve_Identifying_and_Data_Collection_on_NAS|Improve Identifying and Data Collecting on NAS]] for more information on defining, testing, and reporting data about NAS.''
-= Tools & Resources =
+= Available Tools and&nbsp;Resources =
 [[TR_-_Adopt_Universal_Screening_for_Pregnant_Women|TR - Adopt Universal Screening for Pregnant Women]]
-{| class="wiki_table"
+= &nbsp; =
-= Sources =
+&nbsp;
 ----
 #[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]
 #[http://www.amchp.org/programsandtopics/BestPractices/InnovationStation/ISDocs/Perinatal%20Substance%20Use.pdf [2]]
-</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
+</div>
 [[Category:SAFE-Full Spectrum Prevention]]

@@ Line 1: / Line 1: @@
-<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
+<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
 Return to&nbsp; [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]
@@ Line 19: / Line 19: @@
 <br/> '''[http://www.ajog.org/article/S0002-9378(16)30383-0/fulltext#tbl4 The role of screening, brief intervention, and referral to treatment in the perinatal period -- Tricia E. Wright, MD, MS]'''<br/> ''Method'':
-*SBIRT -- Screening, Brief Intervention, and Referral to Treatment --> Figure 2: SBIRT Flow Chart
+''Screening Instruments:''
-<div class="objectEmbed">[[File/view/Figure_2.ppt/614158923/Figure_2.ppt|[File:http://www.wikispaces.com/i/mime/32/application/vnd.ms-powerpoint.png Figure 2.ppt]]] <div>[[File/view/Figure_2.ppt/614158923/Figure_2.ppt|Figure 2.ppt]]
 *CAGE -- Cut down, Annoyed, Guilt, Eye opener
 *T-ACE -- Takes, Annoyed, Cut down, Eye opener
@@ Line 86: / Line 75: @@
 #[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]
 #[http://www.amchp.org/programsandtopics/BestPractices/InnovationStation/ISDocs/Perinatal%20Substance%20Use.pdf [2]]
-</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
+</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
 [[Category:SAFE-Full Spectrum Prevention]]

@@ Line 1: / Line 1: @@
-<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
+<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
 Return to&nbsp; [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]
@@ Line 68: / Line 68: @@
 [[TR_-_Adopt_Universal_Screening_for_Pregnant_Women|TR - Adopt Universal Screening for Pregnant Women]]
-<div class="mw-parser-output">
 {| class="wiki_table"
 |-
@@ Line 88: / Line 86: @@
 #[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]
 #[http://www.amchp.org/programsandtopics/BestPractices/InnovationStation/ISDocs/Perinatal%20Substance%20Use.pdf [2]]
-</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
+</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
 [[Category:SAFE-Full Spectrum Prevention]]

← Older revision		Revision as of 20:17, 15 March 2020
Line 1:		Line 1:
−	<~~parsererror xmlns~~="http://www.~~mozilla~~.org/~~newlayout~~/~~xml~~/~~parsererror~~.~~xml~~">~~XML Parsing Error~~: ~~syntax error~~</~~parsererror~~>	+	<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
		+	Return to  [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use\|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]
		+
		+	__TOC__
		+
		+	<br/> Another potential strategy is to universally screen all pregnant women for substance abuse. In Kaiser Permanente's [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start ]program, pregnant women were screened for substance abuse risk at the first prenatal visit by a self-administered questionnaire and by urine toxicology testing (with signed consent). Universal screening facilitates early identification and treatment of substance use.<sup class="reference">[1]</sup><br/> <br/> '''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start: An Integrated Model of Substance Abuse Intervention for Pregnant Women] - Kaiser Permanente'''<br/> ''Overview of program'':
		+
		+	*Universally screen all pregnant women
		+	*No mandated reporting for toxicology
		+	*Mental health provider apart of obstetric care
		+	*Use video conferencing and telephone to provide care to immediate and remote care
		+
		+	''Outcome Successes'':
		+
		+	*Show decrease in morbidity for mothers and babies
		+	*Cost beneficial
		+	*Reduces all barriers to care, including in prenatal care
		+
		+	<br/> '''[http://www.ajog.org/article/S0002-9378(16)30383-0/fulltext#tbl4 The role of screening, brief intervention, and referral to treatment in the perinatal period -- Tricia E. Wright, MD, MS]'''<br/> ''Method'':
		+
		+	*SBIRT -- Screening, Brief Intervention, and Referral to Treatment --> Figure 2: SBIRT Flow Chart
		+	<div class="objectEmbed">[[File/view/Figure_2.ppt/614158923/Figure_2.ppt\|[File:http://www.wikispaces.com/i/mime/32/application/vnd.ms-powerpoint.png Figure 2.ppt]]] <div>[[File/view/Figure_2.ppt/614158923/Figure_2.ppt\|Figure 2.ppt]]
		+	*[[File/detail/Figure_2.ppt\|Details]]
		+	*[[File/view/Figure_2.ppt/614158923/Figure_2.ppt\|Download]]
		+	*659 KB
		+	</div> </div>
		+	*Components of Interview: raise subject, provide feedback, enhance motivation, negotiate plan
		+	*Purpose of screening for substance abuse is to stratify women into zones of risk given their pattern of use --> Use "risk pyramid" seen in Figure 1.
		+	<div class="objectEmbed">[[File/view/Figure_1.ppt/614158873/Figure_1.ppt\|[File:http://www.wikispaces.com/i/mime/32/application/vnd.ms-powerpoint.png Figure 1.ppt]]] <div>[[File/view/Figure_1.ppt/614158873/Figure_1.ppt\|Figure 1.ppt]]
		+	*[[File/detail/Figure_1.ppt\|Details]]
		+	*[[File/view/Figure_1.ppt/614158873/Figure_1.ppt\|Download]]
		+	*1 MB
		+	</div> </div> <br/> ''Screening Instruments:''
		+	*
		+	**CAGE -- Cut down, Annoyed, Guilt, Eye opener
		+	**T-ACE -- Takes, Annoyed, Cut down, Eye opener
		+	**TWEAK -- Tolerance, Worry, Eye opener, Amnesia, Cut down
		+	**4Ps -- Past, Present, Parents, Partner
		+	**NIDA Quick Screen -- Uses 3 open-ended questions regarding alcohol, tobacco, and other drugs
		+
		+	''Key Screening Conclusions:''
		+
		+	*Screening should be done for all pregnant women and throughout pregnancy for those at risk
		+	*Screening can be done by a provider using a validated instrument during follow-up or by asking standardized questions during interview
		+	*Screening must be nonjudgemental and open-ended
		+	*Urine toxicology should not be used in place of screening
		+
		+
		+
		+	= Promising Practices for Standardized Screening =
		+
		+	== Indiana State Department of Health ==
		+
		+	In 2014, because of the high rate of opioid prescriptions, the Indiana General Assembly charged the Indiana State Department of Health (ISDH) to: develop a standard clinical definition of NAS and a standardized process of identifying it, identify the resources hospitals need to do this, and then establish a voluntary pilot program with hospitals to implement this standardized NAS identification. As of 2016, 26 of 89 Indiana Birthing Hospitals are taking part in this pilot screening program
		+
		+	To understand and address perinatal substance use, accurate data needed to be collected through '''standardized screening and testing:'''
		+
		+
		+
		+	*When any pregnant arrives at the hospital for delivery, hospital personnel conduct a standardized and validated verbal screening regarding substance use.
		+	*Any woman with a positive verbal screen at any point during pregnancy, including at presentation for delivery, is requested to consent to a urine toxicology screening.
		+	*Babies whose mothers had a positive verbal screen or toxicology screen, or babies whose mothers did not consent to the toxicology screen will be tested for evidence of maternal substance use using the infant’s umbilical cord.
		+	**Note: Umbilical cord testing, not meconium stool, was used on all infants.
		+	*Babies also have modified Finnegan scoring initiated to observe for signs and symptoms of NAS.
		+
		+	<br/> ISDH noted that universal screening in a [[Shift_from_Punishment_to_Treatment_Approach_for_Opioid_Users\|non-punitive]] environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.<sup class="reference">[2]</sup><br/> <br/> ''See [[Improve_Identifying_and_Data_Collection_on_NAS\|Improve Identifying and Data Collecting on NAS]] for more information on defining, testing, and reporting data about NAS.''<br/>
		+
		+	= Tools & Resources =
		+
		+	[[TR_-_Adopt_Universal_Screening_for_Pregnant_Women\|TR - Adopt Universal Screening for Pregnant Women]]
		+	<div class="mw-parser-output">
		+	= Scorecard Building =
		+
		+	Potential Objective Details(Under construction) <br/> Potential Measures and Data Sources(Under construction) <br/> Potential Actions and Partners(Under construction)
		+	</div>
		+	= Resources to Investigate =
		+
		+	[[RTI_-_Adopt_Universal_Screening_for_Pregnant_Women\|More RTI on Adopt Universal Screening for Pregnant Women]]<br/> <br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">PAGE MANAGER</span>:''' </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[insert name here]</span><br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">SUBJECT MATTER EXPERT</span>''': </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[fill out table below]</span>
		+
		+	{\| class="wiki_table"
		+	\|-
		+	\| '''Reviewer'''
		+	\| '''Date'''
		+	\| '''Comments'''
		+	\|-
		+	\|
		+	\|
		+	\|
		+	\|}
		+
		+	= Sources =
		+
		+	----
		+
		+	#[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]
		+	#[http://www.amchp.org/programsandtopics/BestPractices/InnovationStation/ISDocs/Perinatal%20Substance%20Use.pdf [2]]
		+	</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
		+	[[Category:SAFE-Full Spectrum Prevention]]

← Older revision		Revision as of 20:16, 15 March 2020
Line 1:		Line 1:
−	<~~div class~~="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">	+	<parsererror xmlns="http://www.mozilla.org/newlayout/xml/parsererror.xml">XML Parsing Error: syntax error</parsererror>
−	Return to  [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use\|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]
−
−	~~__TOC__~~
−
−	<br/> Another potential strategy is to universally screen all pregnant women for substance abuse. In Kaiser Permanente's [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start ]program, pregnant women were screened for substance abuse risk at the first prenatal visit by a self-administered questionnaire and by urine toxicology testing (with signed consent). Universal screening facilitates early identification and treatment of substance use.<sup class="reference">[1]</sup><br/> <br/> '''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start: An Integrated Model of Substance Abuse Intervention for Pregnant Women] - Kaiser Permanente'''<br/> ''Overview of program'':
−
−	*Universally screen all pregnant women
−	*No mandated reporting for toxicology
−	*Mental health provider apart of obstetric care
−	*Use video conferencing and telephone to provide care to immediate and remote care
−
−	~~''Outcome Successes'':~~
−
−	*Show decrease in morbidity for mothers and babies
−	*Cost beneficial
−	*Reduces all barriers to care, including in prenatal care
−
−	~~<br/> '''[~~http://www.~~ajog~~.org/~~article~~/~~S0002-9378(16)30383-0~~/~~fulltext#tbl4 The role of screening, brief intervention, and referral to treatment in the perinatal period -- Tricia E~~. ~~Wright, MD, MS]'''<br/> ''Method'':~~
−
−	*SBIRT -- Screening, Brief Intervention, and Referral to Treatment --> Figure 2: SBIRT Flow Chart
−	~~<div class="objectEmbed~~">~~[[File/view/Figure_2.ppt/614158923/Figure_2.ppt\|[File~~:~~http://www.wikispaces.com/i/mime/32/application/vnd.ms-powerpoint.png Figure 2.ppt]]]~~ <~~div>[[File/view~~/~~Figure_2.ppt/614158923/Figure_2.ppt\|Figure 2.ppt]]~~
−	*[[File/detail/Figure_2.ppt\|Details]]
−	*[[File/view/Figure_2.ppt/614158923/Figure_2.ppt\|Download]]
−	*659 KB
−	~~</div~~> ~~</div>  ~~
−	*Components of Interview: raise subject, provide feedback, enhance motivation, negotiate plan
−	*Purpose of screening for substance abuse is to stratify women into zones of risk given their pattern of use --> Use "risk pyramid" seen in Figure 1.
−	<div class="objectEmbed">[[File/view/Figure_1.ppt/614158873/Figure_1.ppt\|[File:http://www.wikispaces.com/i/mime/32/application/vnd.ms-powerpoint.png Figure 1.ppt]]] <div>[[File/view/Figure_1.ppt/614158873/Figure_1.ppt\|Figure 1.ppt]]
−	*[[File/detail/Figure_1.ppt\|Details]]
−	*[[File/view/Figure_1.ppt/614158873/Figure_1.ppt\|Download]]
−	*1 MB
−	~~</div> </div> <br/> ''Screening Instruments:''~~
−	*
−	**CAGE -- Cut down, Annoyed, Guilt, Eye opener
−	**T-ACE -- Takes, Annoyed, Cut down, Eye opener
−	**TWEAK -- Tolerance, Worry, Eye opener, Amnesia, Cut down
−	**4Ps -- Past, Present, Parents, Partner
−	**NIDA Quick Screen -- Uses 3 open-ended questions regarding alcohol, tobacco, and other drugs
−
−	~~''Key Screening Conclusions:''~~
−
−	*Screening should be done for all pregnant women and throughout pregnancy for those at risk
−	*Screening can be done by a provider using a validated instrument during follow-up or by asking standardized questions during interview
−	*Screening must be nonjudgemental and open-ended
−	*Urine toxicology should not be used in place of screening
−
−	~~ ~~
−
−	~~= Promising Practices for Standardized Screening =~~
−
−	~~== Indiana State Department of Health ==~~
−
−	In 2014, because of the high rate of opioid prescriptions, the Indiana General Assembly charged the Indiana State Department of Health (ISDH) to: develop a standard clinical definition of NAS and a standardized process of identifying it, identify the resources hospitals need to do this, and then establish a voluntary pilot program with hospitals to implement this standardized NAS identification. As of 2016, 26 of 89 Indiana Birthing Hospitals are taking part in this pilot screening program
−
−	~~  To understand and address perinatal substance use, accurate data needed to be collected through '''standardized screening and testing:'''~~
−
−	~~ ~~
−
−	*When any pregnant arrives at the hospital for delivery, hospital personnel conduct a standardized and validated verbal screening regarding substance use.
−	*Any woman with a positive verbal screen at any point during pregnancy, including at presentation for delivery, is requested to consent to a urine toxicology screening.
−	*Babies whose mothers had a positive verbal screen or toxicology screen, or babies whose mothers did not consent to the toxicology screen will be tested for evidence of maternal substance use using the infant’s umbilical cord.
−	**Note: Umbilical cord testing, not meconium stool, was used on all infants.
−	*Babies also have modified Finnegan scoring initiated to observe for signs and symptoms of NAS.
−
−	<br/> ISDH noted that universal screening in a [[Shift_from_Punishment_to_Treatment_Approach_for_Opioid_Users\|non-punitive]] environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.<sup class="reference">[2]</sup><br/> <br/> ''See [[Improve_Identifying_and_Data_Collection_on_NAS\|Improve Identifying and Data Collecting on NAS]] for more information on defining, testing, and reporting data about NAS.''<br/>
−
−	~~= Tools & Resources =~~
−
−	~~[[TR_-_Adopt_Universal_Screening_for_Pregnant_Women\|TR - Adopt Universal Screening for Pregnant Women]]~~
−
−	~~<div class="mw-parser-output">~~
−	~~= Scorecard Building =~~
−
−	~~Potential Objective Details(Under construction) <br/> Potential Measures and Data Sources(Under construction) <br/> Potential Actions and Partners(Under construction) ~~
−	~~</div>~~
−
−	~~= Resources to Investigate =~~
−
−	[[RTI_-_Adopt_Universal_Screening_for_Pregnant_Women\|More RTI on Adopt Universal Screening for Pregnant Women]]<br/> <br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">PAGE MANAGER</span>:''' </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[insert name here]</span><br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">SUBJECT MATTER EXPERT</span>''': </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[fill out table below]</span>
−
−	~~{\| class="wiki_table"~~
−	\|-
−	~~\| '''Reviewer'''~~
−	~~\| '''Date'''~~
−	~~\| '''Comments'''~~
−	\|-
−	~~\|  ~~
−	~~\|  ~~
−	~~\|  ~~
−	\|}
−
−	~~= Sources =~~
−
−	~~----~~
−
−	~~#[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]~~
−	~~#[http://www.amchp.org/programsandtopics/BestPractices/InnovationStation/ISDocs/Perinatal%20Substance%20Use.pdf [2]]~~
−	~~</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>~~
−	~~[[Category:SAFE-Full Spectrum Prevention]]~~

@@ Line 70: / Line 70: @@
 [[TR_-_Adopt_Universal_Screening_for_Pregnant_Women|TR - Adopt Universal Screening for Pregnant Women]]
 = Scorecard Building =
-[[PO_-_Adopt_Universal_Screening_for_Pregnant_Women|Potential Objective Details]]<br/> [[PM_-_Adopt_Universal_Screening_for_Pregnant_Women|Potential Measures and Data Sources]]<br/> [[PA_-_Adopt_Universal_Screening_for_Pregnant_Women|Potential Actions and Partners]]
+Potential Objective Details(Under construction)&nbsp;<br/> Potential Measures and Data Sources(Under construction)&nbsp;<br/> Potential Actions and Partners(Under construction)&nbsp;
 = Resources to Investigate =